Skip to main content

Table 2 Comparison between cognitive performance on the cognitive domains evaluated at baseline and after 12 months of follow-up according the presence of CMBs

From: Clinical impact of microbleeds in patients with Alzheimer’s disease

 

No microbleeds

Microbleeds

Difference

 

p value

p value

adjusted¥

Mean (sd)

Mean (sd)

Mean (95% CI)

Global cognition

 MMSE

(n = 38)

(n = 45)

   

  Baseline

23.06 (2.52)

23.17 (2.29)

   

  12 months

23.13 (3.20)

21.67 (3.02)

   

  Change

−0.65 (−1.18 to 1.05)

1.50 (0.58 to 2.71)

1.57 (−0.04 to 3.17)

0.057

0.399

Verbal memory, recognition

 Recognition (CVLT)

(n = 39)

(n = 45)

   

  Baseline

−0.38 (1.43)

−0.80 (1.67)

   

  12 months

−0.28 (1.34)

−0.56 (2.22)

   

  Change

0.10 (1.25)

0.24 (2.70)

−0,14 (−1.07 to 0.79)

0.463

0.340

Long-term memory

 Long-term verbal memory, with clues (CVLT)

(n = 41)

(n = 44)

   

  Baseline

−1.95 (1.02)

−2.18 (0.89)

   

  12 months

−1.90 (1.04)

−1.78 (0.90)

   

 Change

0.05 (1.18)

0.40 (1.19)

−0.35 (−0,86 to 0.16)

0.175

0.403

  Long-term visual memory RCFT

(n = 38)

(n = 44)

   

  Baseline

4.00 (2.60)

4.07 (2.57)

   

  12 months

4.84 (2.83)

3.64 (2.59)

   

  Change

0.84 (2.19)

−0.43 (2.45)

1.27 (0.25 to 2.31)

0.016

0.471

Short-term memory

 Short-term verbal memory (CVLT)

(n = 41)

(n = 45)

   

  Baseline

−1.66 (1.04)

−1.98 (0.75)

   

  12 months

−2.00 (1.69)

−1.84 (0.74)

   

  Change

−0.34 (1.79)

0.13 (0.82)

−0.47 (−1.06 to 0.12)

0.113

0.07

 Short-term visual memory RCFT

(n = 39)

(n = 44)

   

  Baseline

4.95 (2.53)

4.64 (2.50)

   

  12 months

5.23 (2.86)

4.48 (2.77)

   

  Change

0.28 (2.67)

−0.16 (2.63)

0.44 (− 0.71 to 1.60)

0.451

0.918

CONSTRUCTIONAL PRAXIS

 Copy of the RCFT

(n = 40)

(n = 44)

   

  Baseline

7.35 (3.71)

6.55 (3.87)

   

  12 months

6.80 (3.88)

6.45 (3.89)

   

  Change

−0.55 (3.96)

−0.09 (4.07)

− 0,46 (−2.20 to 1.29)

0.602

0.404

EXECUTIVE FUNCTIONS

 Stroop word-color

(n = 40)

(n = 43)

   

  Baseline

7.75 (2.97)

8.23 (3.78)

   

  12 months

8.43 (3.45)

7.63 (4.36)

   

  Change

0.68 (3.85)

−0.61 (4.50)

1.29 (− 0.55 to 3.11)

0.170

0.855

 Stroop interference

(n = 40)

(n = 42)

   

  Baseline

38.23 (10.06)

41.43 (11.48)

   

  12 months

42.10 (11.61)

41.60 (14.71)

   

  Change

3.88 (14.13)

0.17 (17.41)

3.71 (−3.24 to 10.66)

0.294

0.784

 Digit span (backwards)

(n = 41)

(n = 45)

   

  Baseline

8.83 (3.04)

8.78 (2.91)

   

  12 months

8.44 (3.00)

8.93 (2.44)

   

  Change

−0.39 (3.37)

0.16 (3.10)

−0.55 (−1.94 to 0.85)

0.822

0.862

 TMT-B

(n = 11)

(n = 6)

   

  Baseline

6.09 (1.70)

8.50 (2.35)

   

  12 months

9.00 (3.82)

8.33 (3.33)

   

  Change

2.91 (4.21)

−0.17 (2.23)

3.08 (−0.25 to 6.40)

0.024

0.832

SPEED PROCESSING

 Stroop words

(n = 40)

(n = 43)

   

  Baseline

9.43 (3.08)

8.63 (3.36)

   

  12 months

8.40 (3.28)

7.67 (3.26)

   

  Change

−1.03 (3.33)

−0.95 (3.48)

− 0,08 (− 1,56 to 1,41)

0.924

0.975

 Stroop color

(n = 40)

(n = 43)

   

  Baseline

10.13 (4.38)

8.98 (4.36)

   

  12 months

8.25 (3.90)

7.70 (4.27)

   

  Change

−1.88 (3.52)

−1.28 (4.61)

−0.60 (−2.38 to 1,19)

0.508

0.751

 TMT-A

(n = 38)

(n = 42)

   

  Baseline

6.61 (3.36)

6.45 (3.11)

   

  12 months

7.21 (3.09)

6.00 (3.39)

   

  Change

0.61 (3.23)

−0.45 (2.64)

1.06 (−0.27 to 2.38)

0.115

0.107

Behavior

 NPI

(n = 40)

(n = 43)

   

  Baseline

13.28 (13.19)

9.40 (12.10)

   

  12 months

13.05 (12.04)

11.00 (13.69)

   

  Change

−0.23 (14.50)

1.61 (13.37)

−1,84 (−7,94 to 2,28)

0.553

0.642

 Cornell

(n = 41)

(n = 42)

   

  Baseline

11.2 (7.53)

9.31 (6.04)

   

  12 months

7.85 (6.88)

6.48 (6.66)

   

  Change

−3.34 (5.36)

−2.83 (6.98)

−0.51 (−3.22 to 2.20)

0.711

0.522

 Zarit

(n = 41)

(n = 41)

   

  Baseline

33.02 (17.74)

26.49 (13.01)

   

  12 months

36.05 (13.68)

38.98 (14.90)

   

  Change

3.02 (16.38)

12.49 (16.84)

−9.47 (−16.77 to −2.17)

0.012

0.031

  1. Adjusted by baseline, age, sex, BMI, hypertension, cardiopathy, educational level, and pharmacological treatment. BMI, body mass index; CI, confidence interval; MMSE, Mini-mental state examination; ADAS-cog, Alzheimer’s Disease Assessment Scale-Cognitive
  2. **MMSE Minimental test, CVLT California Verbal Learning Test, RCF Rey-Osterrieth Complex Figure Test, TMT-A Trail Making Test A, TMT-B Trail Making Test B, NPI Neuropsychiatric Inventory